UN Calls for $600M in Aid to Stop Ebola

The United Nations and medical organizations request additional international action on Ebola as the pace of the ongoing epidemic accelerates.

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

CDC PUBLIC HEALTH IMAGE LIBRARYIn the last week alone, 400 people died from Ebola infection, Reuters reported, suggesting the ongoing outbreak, which has to date killed 1,900, is accelerating. To curb the spread of the fatal virus will likely take $600 million, United Nations (UN) officials have announced. In a joint appeal for additional action with Doctors Without Borders, the UN has called for countries to send military and biohazard experts to West Africa. Jan Eliasson, UN deputy secretary general, said at a meeting of the General Assembly this week that the outbreak was “a test to international solidarity,” according to The New York Times. Joanne Liu of Doctors Without Borders said this week it was “impossible to keep up with the sheer number of infected people pouring into our facilities,” according to BBC News. “Six months into the worst Ebola epidemic in history, the world is losing the battle to contain it,” Liu continued. “Leaders are failing to come to grips with this transnational threat.”

While Guinea, Libera, and Sierra Leone have been the three hardest-hit countries, Nigeria and Senegal have also confirmed cases of Ebola. Last week, officials confirmed additional cases of Ebola infection in the Democratic Republic of Congo, although those were deemed unrelated to the growing epidemic in West Africa, the World Health Organization (WHO) reported.

Yesterday (September 3), the WHO issued a preliminary assessment of newly reported infections in Port Harcourt, Nigeria’s oil hub. “The case history of the index case in Port Harcourt is important, as it reveals multiple high-risk opportunities for transmission of the virus to others,” the organization said, noting that this person had “numerous contacts with the community” there before and while he was in the hospital. He died six says after ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies